Massive heart biobank aims to unlock genetic secrets of cardiovascular disease

NCT ID NCT06976502

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study collects blood and tissue samples from up to 500,000 adults, including heart patients, their family members, and healthy individuals. Researchers will analyze these samples to find molecular and genetic markers linked to heart disease. The goal is to improve understanding of cardiovascular conditions and guide the development of new diagnostic tools and treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this biobank could help identify new genetic and molecular markers for heart disease, leading to earlier detection and better treatments.
What could go wrong: This is an observational biobank study, not a clinical trial testing a specific treatment. It may take years to yield actionable results, and findings may not directly translate into new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder heart disorder vascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC DISEASES CARDIOVASCULAR DISEASES HEART DISEASES VASCULAR DISEASES

Contacts and locations

Show contact details

Locations

University of California, San Francisco

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.